Finding markers of relapsing nerve inflammation in children
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at children who have had a first attack of nerve inflammation (like ADEM, vision loss, or spinal cord issues) to find markers in the blood that might show if it will come back. It tests blood and cells to better understand the immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 1 and 18 years old.
- They must have had a first attack of nerve inflammation (ADEM, optic neuritis, or myelitis).
- Blood tests and MRI scans must be available from the time of the first attack.
- No immune-suppressing treatments in the 6 months before the first attack.
- No high-dose steroids or IV treatments in the 3 months before the first attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children with a condition called ADEM, which causes brain swelling and nerve damage. The goal is to find out what factors predict how a child will recover, which could help doctors guide treatment and expected outcomes.
This study is a registry that collects health information from children and teens in Switzerland diagnosed with certain inflammatory brain and spinal cord conditions. It helps researchers understand these illnesses better over time and may guide future treatments.
This study looks at children with ADEM (a sudden brain inflammation) to find signs that could predict how the disease will progress. By studying their brain scans and spinal fluid, doctors hope to learn more about the condition and improve future care.
This study follows people with certain inflammatory conditions of the brain and spinal cord (like MS, NMOSD, or MOGAD) to learn more about their disease. If you join, you will help researchers understand these conditions better.
This study is a registry that collects information from people diagnosed with certain neuroinflammation conditions. It may help doctors learn how these diseases behave over time and support future research.
This study looks for biomarkers (biological clues) in people with autoimmune diseases of the nervous system. It aims to discover better ways to diagnose and treat these conditions.
Hear when a new Acute Disseminated Encephalomyelitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.